The DEA fights to keep psychedelic drugs illegal while it admits these drugs have valuable medical uses. Meanwhile, Americans are dying every day from lack of legal access.
The DEA fights to keep psychedelic drugs illegal while it admits these drugs have valuable medical uses. Meanwhile, Americans are dying every day from lack of legal access.
As investors look to fine-tune their portfolios after the summer, we review the psychedelic drug industry and public company performance in 2021.
Psychedelic drugs are demonstrating unique anti-addiction properties in clinical studies, in a world where over 1 billion people have substance abuse issues.
Two billion treatable (but untreated) mental health disorders globally. Eight million preventable deaths per year. The medicines that can save these lives are still illegal.
Patent protection is of critical importance to the emerging psychedelic drug industry. With two types of drug patents and much additional patentable IP, there is much for investors to learn.
The Mental Health Crisis is now a mental health pandemic. Is access to psychedelic medicine the world's largest human rights issue?
Two billion people have treatable mental health disorders. Where existing therapies are merely inadequate crutches, psychedelic drugs can produce cures.
Psychedelic Stock Watch compares and contrasts the drug development opportunities with psychedelic drugs (and psychedelic drug stocks).
The Mental Health Crisis has been ignored for decades. Covid-19 has made this mental health catastrophe much worse -- and people are now starting to notice.
We explain why addiction therapy likely offers the greatest long-term commercialization potential within the psychedelic drug industry.
Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry
Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now